The unveiling of a novel mechanism of resistance to immunotherapy targeting HER2

Latest survey findings indicate significant decline in molecular testing for cancer during COVID-19 pandemic
23 February 2021
Researcher develops, tests nano-carrier as potential treatment for glioblastomas
23 February 2021

The unveiling of a novel mechanism of resistance to immunotherapy targeting HER2

Immunotherapy continues to show exciting promise in more effectively combating several tumor types. Many current strategies focus on ensuring the efficient delivery of active cytotoxic cells directly to tumors. It is thought that once the lymphocytes engage to cancer cells they will unfailingly destroy them, provided that inhibitory mechanisms are in check.

Comments are closed.